On July 1st, 2023, Australia’s Therapeutic Goods Administration (TGA) will begin allowing government-registered psychiatrists to use MDMA in the treatment of posttraumatic stress disorder (PTSD) and treatment-resistant depression. Australia joins Canada, Israel, and the United States in establishing a policy permitting the use of an unapproved drug outside of clinical…